Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
about
Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: data from a national US cohort.Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?Long-term follow-up of patients triply infected with HIV and hepatitis B and C viruses in a comprehensive hospital in central China.Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection.Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.What do clinicians need to watch for with direct-acting antiviral therapy?Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?Inhibitory effect of silibinin on hepatitis B virus entry.Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860
Q38606004-B4FC12E2-7906-4E37-9A21-37ACEDE0DAE6Q40096207-36C4E496-0637-4FA9-B8E3-16F36B647D68Q40152784-AC76CC2B-F80F-4C65-8126-59DE18785F74Q42374435-D54714B4-196B-45FD-9C54-C7E45EE02171Q45323928-F517A64E-9AD2-467D-9FD8-DE54516E2B5CQ45324158-AF14DAA1-B978-4A84-80F8-96D134CEBEC3Q46856544-BB50B3C4-3045-4BA6-A717-E261233E552DQ47549948-66F2A81F-37A8-4056-B56C-2C16FEBAFE9DQ47561355-3ACCCA6D-373D-4B59-B3A4-8A923FD4563EQ47615517-79981904-9352-4FFE-92E2-5D98C917160FQ50190669-35B30133-4A83-408C-9BA0-85212090BF60Q52327014-0BB211D5-1AF9-4EAC-96D2-7A318B65F583Q54222473-5B683A13-31A3-4CB7-8E59-737372DDAF4EQ54249544-3FFC0416-805E-4739-AFF8-CC7DE4D23A32Q54367809-2BAA50AF-5197-4832-805A-0084032FA6F5Q55228735-7402A886-E5AD-464F-A5D3-F50D7C723984Q55384194-EEFD9BBC-F7B0-45EC-A9F9-7AE3FB4A33E2Q58788714-828C2189-9CA4-40A4-BC49-CEF2A7EE9906
P2860
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Hepatitis B Virus Reactivation ...... dverse Event Reporting System.
@en
type
label
Hepatitis B Virus Reactivation ...... dverse Event Reporting System.
@en
prefLabel
Hepatitis B Virus Reactivation ...... dverse Event Reporting System.
@en
P2093
P356
P1476
Hepatitis B Virus Reactivation ...... dverse Event Reporting System.
@en
P2093
Adebola Ajao
Allen Brinker
Mihaela Jason
S Christopher Jones
Susan J Bersoff-Matcha
Tamra Meyer
P304
P356
10.7326/M17-0377
P407
P577
2017-04-25T00:00:00Z